A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with moderately to severely active ulcerative colitis. A total of 120 subjects are planned to be included.

Timeline

Start

2025-05-22

Primary completion

2026-07-30

Completion

2026-12-31

Drugs

Indications